175 related articles for article (PubMed ID: 31606304)
1. Is the computerized assessment of psychomotor speed more sensitive to cognitive effects of antiepileptic pharmacotherapy than tests with a focus on higher-order cognitive processing? Implications for the choice of sensitive test parameters.
Helmstaedter C; Durch P; Hoppe C; Witt JA
Eur Neuropsychopharmacol; 2019 Nov; 29(11):1273-1281. PubMed ID: 31606304
[TBL] [Abstract][Full Text] [Related]
2. Adverse cognitive effects of antiepileptic pharmacotherapy: Each additional drug matters.
Witt JA; Elger CE; Helmstaedter C
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1954-9. PubMed ID: 26296280
[TBL] [Abstract][Full Text] [Related]
3. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
Lutz MT; Helmstaedter C
Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
[TBL] [Abstract][Full Text] [Related]
4. Antiepileptic drug effects on subjective and objective cognition.
Quon RJ; Mazanec MT; Schmidt SS; Andrew AS; Roth RM; MacKenzie TA; Sajatovic M; Spruill T; Jobst BC
Epilepsy Behav; 2020 Mar; 104(Pt A):106906. PubMed ID: 32006792
[TBL] [Abstract][Full Text] [Related]
5. EpiTrack is a feasible tool for assessing attention and executive functions in patients with refractory epilepsy.
Lähde N; Basnyat P; Lehtinen H; Rainesalo S; Rosti-Otajärvi E; Peltola J
Epilepsy Behav; 2021 Feb; 115():107691. PubMed ID: 33360402
[TBL] [Abstract][Full Text] [Related]
6. Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy.
McGuire AM; Duncan JS; Trimble MR
Epilepsia; 1992; 33(1):128-34. PubMed ID: 1733746
[TBL] [Abstract][Full Text] [Related]
7. Mental slowing in relation to epilepsy and antiepileptic medication.
Grevers E; Breuer LE; IJff DM; Aldenkamp AP
Acta Neurol Scand; 2016 Aug; 134(2):116-22. PubMed ID: 26918421
[TBL] [Abstract][Full Text] [Related]
8. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
Hessen E; Lossius MI; Reinvang I; Gjerstad L
Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
[TBL] [Abstract][Full Text] [Related]
9. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
Feldman L; Lapin B; Busch RM; Bautista JF
Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the mediating role of executive functions for antiepileptic drugs' effects on IQ in children and adolescents with epilepsy.
Helmstaedter C; Witt JA; Hoppe C
Epilepsy Behav; 2019 Jul; 96():98-103. PubMed ID: 31121514
[TBL] [Abstract][Full Text] [Related]
11. Cognitive consequences of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery, the TimeToStop (TTS) trial: study protocol for a randomized controlled trial.
Boshuisen K; Lamberink HJ; van Schooneveld MM; Cross JH; Arzimanoglou A; van der Tweel I; Geleijns K; Uiterwaal CS; Braun KP
Trials; 2015 Oct; 16():482. PubMed ID: 26503021
[TBL] [Abstract][Full Text] [Related]
12. Affective and behavioral dysfunction under antiepileptic drugs in epilepsy: Development of a new drug-sensitive screening tool.
Mertens LJ; Witt JA; Helmstaedter C
Epilepsy Behav; 2018 Jun; 83():175-180. PubMed ID: 29709877
[TBL] [Abstract][Full Text] [Related]
13. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
[TBL] [Abstract][Full Text] [Related]
14. Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures.
Salinsky MC; Oken BS; Storzbach D; Dodrill CB
Epilepsia; 2003 Aug; 44(8):1042-50. PubMed ID: 12887435
[TBL] [Abstract][Full Text] [Related]
15. Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy.
IJff DM; van Veenendaal TM; Majoie HJ; de Louw AJ; Jansen JF; Aldenkamp AP
Acta Neurol Scand; 2015 Jun; 131(6):347-54. PubMed ID: 25630655
[TBL] [Abstract][Full Text] [Related]
16. Short-term and longer-term effects of brivaracetam on cognition and behavior in a naturalistic clinical setting-Preliminary data.
Witt JA; Elger CE; Helmstaedter C
Seizure; 2018 Nov; 62():49-54. PubMed ID: 30278348
[TBL] [Abstract][Full Text] [Related]
17. Cognition in school-aged children with "active" epilepsy: A population-based study.
Reilly C; Atkinson P; Das KB; Chin RF; Aylett SE; Burch V; Gillberg C; Scott RC; Neville BG
J Clin Exp Neuropsychol; 2015; 37(4):429-38. PubMed ID: 25921696
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.
Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C
Seizure; 2018 May; 58():141-146. PubMed ID: 29704679
[TBL] [Abstract][Full Text] [Related]
19. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
20. Attention and executive functions in the early course of pediatric epilepsy.
Reuner G; Kadish NE; Doering JH; Balke D; Schubert-Bast S
Epilepsy Behav; 2016 Jul; 60():42-49. PubMed ID: 27179191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
